NCT07376421

Brief Summary

Peristomal skin complications (PSCs) are the predominant complication for people living with a stoma, which affect their quality of life negatively. Among the main reasons for developing PSCs are that the peristomal skin is exposed to stomal output either due to leakage of output under the baseplate and/or imperfect cutting of the hole in the baseplate, and incorrect application creating a gap between the hole in the baseplate and the stoma. To seal this gap, Coloplast has developed a new ostomy baseplate and the aim of the investigation is to explore the investigational device 's ability to help protect the peristomal skin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

January 24, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 29, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2026

Completed
Last Updated

May 1, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

January 22, 2026

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maximum itching scale 0-10)

    Itching score (weekly max at steady state\* scale 0-10). \* To account for a possible carry-over effect, the steady state period of the treatment period begins after two weeks of investigational device or comparator use. It is anticipated that the skin will have adapted to the new device after two weeks.

    8 weeks

Study Arms (2)

Investigational device

EXPERIMENTAL

4 weeks treatment with investigational device

Device: Incestigational device

Comparator

ACTIVE COMPARATOR

4 weeks treatment with investigational device

Device: Comparator

Interventions

4 weeks treatment with comparator

Comparator

4 weeks treatment with investigational device

Investigational device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has given written consent
  • Is at least 18 years of age
  • Has full legal capacity
  • Has an ileostomy with consistent liquid fecal output (6-7 Bristol scale).
  • Has had the stoma for at least 90 days.
  • Has a stoma size less than 40mm in diameter
  • Has experienced leakage under the baseplate at least three times within the last 14 days.
  • Leakage defined as output/seeping under the baseplate (see Appendix A)
  • Has experienced symptoms of peristomal skin complications such as itching, burning, or pain in the peristomal area within the last 14 days.
  • Has suitable peristomal skin area (assessed by investigator)
  • Is able to handle the electronic diary (questionnaire/photo) themselves. If needed, a trained spouse or caretaker is allowed to assist.
  • Is able to handle (apply, remove, etc.) the investigational devices themselves.
  • Understands that any supporting products under the baseplate are not permissible during the investigation (except for adhesive removers) and is willing to not use these during the investigation.
  • Is willing and suitable (determined by the Principal Investigator or designee) to use a flat 2-piece device during the investigation.
  • Is willing to change the baseplate at least every third/fourth day during the investigation.

You may not qualify if:

  • Is currently receiving or have within the past 60 days received radio-and/or chemotherapy.
  • Low doses radio- and/or chemotherapy (assessed by Principal Investigator) is allowed for other indications than cancer.
  • Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g., lotion or spray treatment.
  • Is breastfeeding.
  • Is pregnant based on urine pregnancy test.
  • Has known hypersensitivity towards any of the investigational devices used in the investigation.
  • Has a complicated stoma at baseline, as assessed by investigator (e.g., dehiscence/prolapse/hernia).
  • Daily use of analgesics, antihistamine or steroid treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Coloplast A/S

Humlebæk, Denmark

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2026

First Posted

January 29, 2026

Study Start

January 24, 2026

Primary Completion

April 9, 2026

Study Completion

April 9, 2026

Last Updated

May 1, 2026

Record last verified: 2026-01

Locations